DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma

PLoS ONE - United States
doi 10.1371/journal.pone.0031507
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Tumor-Stroma Interactions in Pancreatic Ductal Adenocarcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Molecular Targeting of Cell-Permeable Peptide Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation

Oncotarget
Oncology
2017English

The BET Inhibitor I-Bet762 Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation and Enhances the Therapeutic Effect of Gemcitabine

Scientific Reports
Multidisciplinary
2018English

B7-H3 Silencing Inhibits Tumor Progression of Mantle Cell Lymphoma and Enhances Chemosensitivity

International Journal of Oncology
Cancer ResearchOncology
2015English

Clinical Significance of MUC13 in Pancreatic Ductal Adenocarcinoma

HPB
HepatologyGastroenterology
2018English

Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in Tumor Tissues Predicts Poor Survival in Pancreatic Ductal Adenocarcinoma

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Nardilysin Inhibits Pancreatitis and Suppresses Pancreatic Ductal Adenocarcinoma Initiation in Mice

Gut
Gastroenterology
2018English

MEX3A Knockdown Inhibits the Development of Pancreatic Ductal Adenocarcinoma

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

Knockdown of B7-H6 Inhibits Tumor Progression and Enhances Chemosensitivity in B-Cell Non-Hodgkin Lymphoma

International Journal of Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy